Search Results 521-530 of 14743 for anti-TNF drugs

  1. Antihemophilic Factor (Recombinant) Pegylated-Aucl (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  2. Gepirone (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  3. Azelastine And Fluticasone (Nasal Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Dymista. Descriptions. Azelastine and fluticasone ...

  4. Peginterferon Beta-1a (Intramuscular Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Plegridy Pen; Plegridy Pen Starter Pack. Descriptions.

  5. Moxifloxacin (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Antihemophilic Factor (Recombinant), Fc-Vwf-Xten Fusion Protein-Ehtl (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Altuviiio. Descriptions.

  7. Mayo Clinic Q and A: Immunotherapy and breast cancer

    Known as checkpoint inhibitors, or PD-1/PD-L1 pathway inhibitors, this treatment aims to prevent the deactivation and increase the body's anti-tumor immune ...

  8. Mayo Clinic Radio: Multiple sclerosis / nonsteroidal anti-inflammatory drugs / bone marrow transplant

    Mayo Clinic Radio: Multiple sclerosis / nonsteroidal anti-inflammatory drugs / bone marrow transplant. By. Jennifer O'Hara. February 27, 2017. Share this: Share ...

  9. Tralokinumab-Ldrm (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Tralokinumab-ldrm injection is used alone or in combination with other medicines (eg, topical corticosteroids) to treat moderate to severe atopic dermatitis in ...

  10. Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA) - Mayo Clinic

    Treated with any anti-cancer therapy within 30 days prior to the first virus injection. Anti-cancer therapy is defined as anti-cancer agents (e.g., surgery ...